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Abstract
Emphysema (Greek word meaning to inflate/to blow) is an increase in the size of 
airspace distal to the terminal bronchiolus, that is, hyperinflation of the alveoli due 
to the destruction of the gas-exchanging structures: alveolar walls, alveolar ducts, 
and respiratory bronchioles with coalescence of airspaces into the abnormal, much 
larger airspaces. The main consequences are the reduction of alveolar surface for gas 
exchange and the chronic obstructive pulmonary disease due to the destruction and 
disappearance of respiratory bronchioles with decreased total small airway diam-
eter sum. Both decreased alveolar surface for gas exchange and chronic obstructive 
pulmonary disease lead to difficulty in breathing with dyspnea varying from mild 
to very severe. Two main pathohistologic types of emphysema are centriacinar and 
panacinar. Centriacinar emphysema involves the central portion of the acinus, 
and inflation mainly involves respiratory bronchioles and adjacent alveoli, and 
not all alveoli inside the acinus are involved. Panacinar (panlobular) emphysema 
is characterized by uniform enlargement and destruction of alveoli throughout 
the entire acinus. The panacinar emphysema is rare and its most common cause is 
hereditary alpha-1 antitrypsin deficiency. The centriacinar emphysema is the most 
frequent emphysema. It is mainly caused by smoking but also by coal dust exposure 
and advanced age.
Keywords: emphysema, chronic obstructive pulmonary disease, smoking, coal 
dust, alpha-1 antitrypsin deficiency, oxidative radicals, telomeres
1. Introduction
Emphysema, enlarged airspaces due to destruction of alveolar walls, respiratory 
bronchioles, and alveolar ducts, is a well-defined disease. However, in the medical 
practice, it is mainly encountered as an essential component of the chronic obstruc-
tive pulmonary disease syndrome. Other components are chronic bronchitis, small 
airway disease, small airway hyperactivity, and inflammation. Chronic obstruc-
tive pulmonary disease presents with cough, sputum production, and exertional 
dyspnea. In advanced cases, patients are breathless while doing even simple daily 
activities and may develop resting hypoxemia (blue cyanotic lips and finger nails) 
that requires continuous application of supplemental oxygen. Chronic obstructive 
pulmonary disease during its course is complicated by viral, bacterial, and fungal 
infections, and pneumonias and chronic obstructive pulmonary disease are the 
fourth leading cause of death in the USA. Urban air pollution and industrial air 
pollution are contributory factors in the genesis of chronic obstructive pulmonary 
disease, and with increase in cigarette smoking in developing countries, an estimate 
is that the chronic obstructive pulmonary disease will rise from the sixth to the 
third most common cause of death worldwide by the year 2020 [1].
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2. Heading
2.1 Morphologic and histologic features of the normal lung
A normal lung consists of airways and alveoli. Airways are tubes (pipes) that 
conduct air to alveoli where gas exchange occurs. Oxygen (O2) through alveolar wall 
enters into red blood cells in the alveolar capillaries and binds to hemoglobin, while 
carbon dioxide (CO2) goes in opposite direction being released from hemoglobin, 
enters alveoli, and is being exhaled.
The trachea beyond the carina undergoes to about 23 generations of dichoto-
mous branching. Airway tubes with diameter of more than 1 mm are called bronchi. 
With each division the diameter of the bronchus becomes smaller, but the sum of 
the two diameters exceeds diameter of the parent bronchus meaning that with divi-
sions resistance to air flow becomes smaller. The bronchus consists of the lumen, 
mucosa, submucosa, muscularis, cartilage, and adventitia that is composed of 
connective tissue and contains lymphatics (Figure 1).
Bronchi are accompanied by branches of the pulmonary artery that have a 
diameter of similar size to the diameter of the bronchus they follow. The mucosa is 
mainly lined by columnar respiratory epithelium with cilia. All columnar cells lie on 
a basement membrane, but since columnar cells differ in their length, nuclei differ 
in their position regarding basal membrane, and respiratory epithelium appears 
stratified, but in fact it is pseudostratified. The mucosa also contains small number 
of mucinous cells that contain apical mucin, small number of basal cells, and rare 
neuroendocrine cells. Basal cells are precursors of ciliated cells and of mucinous 
goblet cells. Cilia arise from the apices of the respiratory cells and serve as escalator 
pushing mucin upstream to the throat and nose. Neuroendocrine cells are scattered 
singly and form small groups, neuroepithelial bodies near the airway bifurcations. 
The functional significance of the neuroendocrine cells is largely unknown. Beneath 
the pseudostratified ciliated mucosa is the submucosa that consists of loose con-
nective tissue harboring bronchial mucous (seromucinous) glands, lymphoid tissue 
aggregates, and plasma cells. Mucinous glands secrete mucus composed of glycopro-
tein, proteoglycans, lipids, IgA (secretory) immunoglobulins, lysozyme peroxidase, 
and other substances to inactivate invading microorganisms, and trap air pollu-
tion particles. Cartilage plate and muscle bundles lie beneath the submucosa. The 
cartilage prevents collapse of the bronchial lumen. There are about 9–12 generations 
of bronchi. The smallest bronchi are 1 mm in diameter. Bronchi branch into the 
bronchiole. Bronchioles are less than 1 mm in diameter and they lack cartilage and 
Figure 1. 
Portion of the wall of the bronchus with respiratory epithelium with cilia, smooth muscle layer, and cartilage.
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exocrine mucinous glands in their walls. The larger bronchioles are called terminal 
bronchioles and measure on average 0.5–1 mm. Since terminal bronchioles do not 
contain cartilage, they are also called membranous bronchioles (Figure 2).
Terminal bronchioles consist of respiratory mucosa composed of one layer 
of cuboidal ciliated respiratory cells and occasional Clara cells. Clara cells are 
non-ciliated columnar epithelial cells with protuberant apical cytoplasm that 
contains granules of surfactant and protease inhibitors. Clara cells are also precur-
sors of bronchiolar epithelial cells. Goblet cells are generally not present or rare 
in the mucosa of the terminal bronchioles. Beneath the mucosa of the terminal 
bronchiolus is a layer of smooth muscle and connective tissue adventitia. Terminal 
bronchioles branch into the respiratory bronchioles. One side of the airway wall of 
the respiratory bronchiolus is lined by simple columnar to cuboidal bronchiolar epi-
thelium without cilia. The opposite wall is lined by alveoli, that is, the wall consists 
of openings of the alveolar sacs. The average diameter of respiratory bronchioles is 
0.15–0.2 mm. The respiratory bronchioles branch into about two more generations 
of respiratory bronchioles. Respiratory bronchioles branch into alveolar ducts, 
straight tubular spaces bounded entirely by alveoli (Figure 3).
In fact all alveoli (alveolar sacs) open into the alveolar ducts. Thus alveoli 
have incomplete wall and alveolar sacs are outpockets of alveolar ducts. Alveoli 
that appear lined with alveolar walls on all sides are in fact artifact of cut section. 
Alveolar ducts are not accompanied by the artery. The acinus is a functional unit 
of the lungs that consists of terminal bronchiolus with its respiratory bronchioles, 
alveolar ducts, and alveoli forming tridimensional spherical space with average 
Figure 2. 
Terminal bronchiolus, lined by respiratory epithelium, with no cartilage and no exocrine glands.
Figure 3. 
Alveolar duct and alveoli (original magnification × 100) and alveolar septa with alveoli (original 
magnification × 400). Courtesy of Dr. Nadia N. Naumova.
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diameter of 7.5 mm. There are about three generations of respiratory bronchioles 
inside the acinus and approximately 25,000 acini in normal adult male lungs with a 
volume of 5.25 liters [2]. Cluster of three to five terminal bronchioles, that is, acini, 
form pulmonary lobule. The pulmonary lobule is an anatomic unit, polygonal in 
shape, and bound by complete or incomplete connective tissue interlobular septa 
and measures about 1.5–3 cm.
Gas exchange starts in respiratory bronchioles and mainly occurs in alveoli. 
The alveolar wall (also called alveolar septum) is very thin in order to permit effi-
cient gas exchange (Figure 3). It consists only of one layer of epithelial cells called 
pneumocytes. Pneumocytes type 1 are very thin, flat, large epithelial cells that 
cover 90% of the alveolar surface and are not capable of mitosis. Pneumocytes 
type 2 are cuboidal cell with large basal nucleus and prominent nucleolus. 
Pneumocytes type 2 secrete surfactant, are able to divide and participate in repair, 
and may become hyperplastic in response to alveolar damage. Pneumocytes 
type 2 are also precursors of pneumocytes type 1. Pneumocytes lie on the basal 
membrane that is fused with the basal membrane of the capillary endothelial cell. 
Thus the alveolar wall (septum) consists only of capillary sandwiched between 
the two layers of pneumocytes from two adjacent alveoli (Figure 3). An occasional 
myofibroblast may be present in the alveolar wall as well as rare scattered small 
lymphocytes, rare mesenchymal cells, and rare macrophages. Hematoxylin and 
eosin-stained sections of the normal lung on high magnification show delicate 
alveolar walls (septa) containing inconspicuous capillaries, occasional cuboidal 
cells of pneumocytes type 2, and nuclei of pneumocytes type 1, endothelial cell 
nuclei, and nuclei of rare scattered lymphocytes, mesenchymal cells, and mac-
rophages. The cytoplasm of pneumocytes type 1 is too thin to be visible without 
special immunoperoxidase stains. Alveolar macrophages egress from capillaries, 
are increased in number in chronic inflammatory settings, and are involved 
in phagocytosis of foreign material as well in the inflammatory and immune 
responses.
The interstitium provides the connective tissue framework of the lungs 
and is composed of collagen fibers, elastic fibers, mesenchymal cells, and few 
inflammatory cells. In normal lungs the interstitium is generally inconspicu-
ous and can be recognized only along bronchovascular bundles, around veins, 
and where it forms interlobular septa. In the children up to 4 years of age, the 
interstitium is more apparent and presents as thickening of the alveolar walls 
[3]. The term “small airways” includes airways with diameter of 2 mm and 
smaller and thus includes small bronchi, terminal bronchioles, and respiratory 
bronchioles.
2.2 Morphologic and histologic features of emphysema
Emphysema is permanent enlargement of airspaces distal to the terminal bron-
chiole (acinus) due to the destruction of the walls of the alveoli, alveolar ducts, and 
the respiratory bronchioles. Grossly, the lung is hyperinflated and spongy.
According to the location of the hyperinflated alveoli inside the acinus, there are 
four types of emphysema: centriacinar (centrilobular, proximal), panacinar (pan-
lobular), distal acinar (paraseptal), and irregular (associated with scar). Each of 
the emphysema type has characteristic microscopic morphology and characteristic 
etiology.
The most frequent is centriacinar emphysema which comprises more than 95% 
of all emphysemas. Centriacinar emphysema involves proximal respiratory bron-
chiolus and adjacent alveoli, which is in the center of the acinus, hence the name 
centriacinar emphysema (Figure 4).
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Inhaled cigarette smoke or mineral dust, most frequently coal mine dust, reach 
respiratory bronchioles. There are no cilia in the respiratory bronchioles; cigarette 
smoke particles and coal dust particles (silica particles in the coal dust are the most 
toxic ones) stick there and initiate processes of inflammation and destruction. 
The first damaged structure is thus respiratory bronchiolus with its dilatation or 
disappearance. In the beginning, alveolar ducts and alveoli are spared. Soon their 
destruction and coalescence into the larger air space follows. In the acinus, which 
contains several (about 14) respiratory bronchioles, some bronchioles and alveoli 
are damaged, enlarged, and emphysematous, and some are not damaged and are 
normal in size. Thus characteristic microscopic feature with low power magnifica-
tion of centroacinar emphysema is that some alveoli are normal and some emphyse-
matous (Figures 4 and 5).
Cigarette smoke produces similar damage, and in fact the most frequent cause of 
centriacinar emphysema is cigarette smoking. Centriacinar emphysema predomi-
nantly involves the upper and posterior portions of the lungs and upper parts of the 
individual lobes. In severe emphysema, emphysematous spaces may coalesce and 
form bullae which may reach several centimeters in diameters. By definition bulla is 
at least 1 cm in diameter. Bullae are usually located in the lung apices and subpleu-
rally but can occur anywhere in the emphysematous lungs.
Figure 5. 
Centriacinar emphysema and interstitial fibrosis caused by birefringent silica/silicate particles from coal mine 
dust. This is the same area as in Figure 4, but with original magnification × 400 and photographed under 
polarized light to highlight birefringent silica/silicate particles; small white dots in the interstitium and silvery 
collagen fibers of interstitial (septal alveolar) fibrosis.
Figure 4. 
Centriacinar emphysema caused by coal mine dust. Some alveoli are normal, some emphysematous. 
Hematoxylin and eosin stain, original magnification 20×.
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Panacinar emphysema (panlobular emphysema) comprises 1% of emphysemas. 
It involves the entire acinus, that is, all alveoli in the acinus are about equally dilated, and 
all acini in the lobule are involved by panacinar (panlobular) emphysema (Figure 6). In 
centriacinar emphysema, some alveoli are enlarged and some are normal.
Panacinar emphysema is associated with alpha-1-antitrypsin deficiency, an 
autosomal codominant genetic disorder. Since defect is present in the gene (chro-
mosome 14, segment q32.1), every cell, in which this gene is active and its product 
anti-protease alpha-1 antitrypsin enzyme pertinent, is affected. Thus all respiratory 
bronchioles, alveolar ducts, and alveoli are affected and about equally damaged and 
equally hyperinflated. The lungs are diffusely affected by panacinar emphysema, and 
histologically there is diffuse enlargement of the alveoli affecting the entire acinus. 
Normal level of alpha-1 antitrypsin in the serum is 20–48  μM / L . P atients with 
emphysema have concentration of serum alpha-1 antitrypsin 2.5–7 μM/L, and they 
are homozygous for PI*ZZ allele (PI* denotes protein inhibitor gene). There are more 
than 90 different alleles of PI* gene, and some variants cause a change in conforma-
tion of the alpha-1-antitrypsin molecule leading to polymerization and retention of 
misshaped protein in hepatocytes (major site of synthesis of alpha-1 antitrypsin) that 
might lead in children as well in adults to cirrhosis of the liver. If there is absence of 
protein inhibitor gene, serum level of alpha-1 antitrypsin is zero. Panacinar emphy-
sema might also occur in intravenous drug abusers and then is accompanied with talc 
granulomas and interstitial fibrosis [3, 4]. Birefringent particles of talk could be seen 
under polarized light in the granulomas and in the fibrotic interstitium (Figure 7).
Distal acinar emphysema (paraseptal emphysema) involves distal part of the 
acinus including alveolar ducts and alveoli. It is rare. Distal acinar emphysema is 
most often present in the upper lobes beneath the pleura and along septa between 
lobules and also is called paraseptal, subpleural, or localized emphysema. The 
pathogenesis of distal acinar emphysema is unknown. Distal acinar emphysema pro-
duces apical bullae which may cause spontaneous pneumothorax in young adults.
Irregular emphysema is airspace enlargement due to lung destruction associated 
with scarring, also termed scar emphysema, paracicatrical emphysema, and perifocal 
emphysema. Foci of irregular emphysema are asymptomatic and clinically insig-
nificant. The National Heart, Lung, and Blood Institute does not regard irregular 
emphysema as a form of emphysema but as “airspace enlargement with fibrosis” [5].
Figure 6. 
Panacinar emphysema (left) and normal lung (right). In panacinar emphysema, all alveoli are enlarged. 
Figure 6, is reproduced with permission from the American Registry of Pathology from the Atlas of Nontumor 
Pathology Series; Non-Neoplastic Disorders of the Lower Respiratory Tract by William D. Travis et al 
published by the American Registry of Pathology and the Armed Forces Institute of Pathology Washington DC, 
USA, Copyright© 2002.
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The pathogenesis of centriacinar and panacinar emphysema is conceptually 
similar and based on proteinase-antiproteinase imbalance, that is, inequity between 
enzymes that degrade the extracellular matrix and proteins that oppose this pro-
teolytic activity [6]. The first clue appeared in 1963 when Laurell and Eriksson 
identified patients with alpha-1 antitrypsin (more appropriate name is alpha-1 
antiproteinase) deficiency on serum electrophoresis who had severe emphysema of 
early onset and in 1964 when Gross and coworkers demonstrated that proteolytic 
enzyme papain can produce emphysema in rats [7, 8]. Alpha-1 antitrypsin is a 
proteinase inhibitor that inhibits proteolytic enzymes, primarily neutrophil elastase. 
Elastase is an enzyme that destroys elastin fibers, and if it is not adequately inhibited 
by alpha-1 antitrypsin, destruction of acinar tissue follows leading to emphysema. 
Imbalance between other proteolytic enzymes (metalloproteinases including inter-
stitial collagenase-1, interstitial collagenase-3, metalloelastase, matrilysin, gelatinase 
A and gelatinase B, cathepsins) and their inhibitors (tissue inhibitors of matrix 
metalloproteinases, elafin, epithelium-derived secretory leukoprotease inhibitor) 
also contributes to emphysema and chronic obstructive pulmonary disease [3, 6].
Cigarette smoking is the most frequent cause of emphysema and accounts to 
80–90% of chronic obstructive pulmonary disease cases in the USA [9]. Cigarette 
smoke and coal mine dust cause emphysema by a similar pathophysiologic 
pathway. Inhaled cigarette smoke as well as coal mining dust particles travel by 
airflow to respiratory bronchioles and alveoli where they interfere with epithelial 
cells, alveolar macrophages, and neutrophils. Cigarette smoke contains per puff 
an estimated 1015–1017 oxidants/free radicals and about 4700 different chemical 
compounds, including reactive aldehydes and quinones [10, 11]. Toxic oxidant 
compounds in cigarette smoke induce DNA damage and peroxidation of lipids, 
harm proteins, fold proteins, and cause them to aggregate in the cytoplasm of 
the respiratory cells and alveolar cells [12]. Alveolar epithelial cells and macro-
phages damaged by cigarette smoke release cytokines which invite inside alveoli 
Figure 7. 
Panacinar emphysema caused by drug abuse. Mild interstitial fibrosis is present as well as birefringent deposits 
of talc in the interstitium. Figure 7 is reproduced with permission from the American Registry of Pathology 
from the Atlas of Nontumor Pathology Series; Non-Neoplastic Disorders of the Lower Respiratory Tract by 
William D. Travis et al published by the American Registry of Pathology and the Armed Forces Institute of 
Pathology Washington DC, USA, Copyright© 2002.
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inflammatory cells mainly macrophages but also T cells (T8 more than T4) and 
small number of neutrophils. Characteristic histologic findings in cigarette smokers 
are tobacco-associated respiratory bronchiolitis with the presence of macrophages 
containing smoker granules (yellow-brown) inside alveoli (Figure 8). Macrophages 
and neutrophils activated by cigarette smoke or silica (quartz) [13] particles in 
coal mine dust release abovementioned proteolytic enzymes that destroy collagen 
and elastic alveolar tissue causing connective tissue breakdown and alveolar tissue 
destruction, that is, emphysema [14]. Oxidative radicals in the cigarette smoke as 
well as quartz-generated hydrogen peroxide not only damage intracellular proteins 
but also inactivate alpha-1 antitrypsin by oxidizing the SH group of methionine to 
methionine sulfoxide [14]. Other proteins, for example, proteasome with caspase-
like activity, are also impaired by this oxidation. The final effect of cigarette smoke 
and inhalation of coal mine dust is unopposed (or insufficiently inhibited) action of 
proteolytic enzymes that destroy lung parenchyma and cause emphysema.
Macrophages also produce transforming growth factor-beta, platelet-derived 
growth factor, and tumor necrosis-alpha, which all stimulate fibroblast growth, col-
lagen production and repair with associated fibrosis [15]. Repair may not be perfect 
and interstitial fibrosis may occur. Bronchioles and small bronchi can be involved 
by fibrosis and contribute to the chronic obstructive pulmonary disease. Tobacco-
caused respiratory bronchiolitis-associated interstitial lung disease with fibrosis 
(Figure 9) is now a plausible and established term [16, 17].
Figure 8. 
Tobacco-associated respiratory bronchiolitis. Macrophages with smoker granules inside alveoli. Hematoxylin 
and eosin stain, original magnification 400×.
Figure 9. 
Tobacco-associated respiratory bronchiolitis with interstitial fibrosis. Hematoxylin and eosin stain, original 
magnification 200×. Right, same picture under polarized light to demonstrate collagen (silvery shine) fibers in 
thickened fibrotic alveolar septa.
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It is obvious that tobacco-associated emphysema and tobacco-associated inter-
stitial fibrosis are related and that the first step in their genesis is accumulation 
of macrophages with smoker granules in the alveoli. The similar process can be 
elicited by silica and silicates from coal mine dust. The first sign of exposure to coal 
mine dust is accumulation of silica/silicate particles and anthracotic pigment in the 
alveolar macrophages (Figure 10) [18].
In coal miners with complicated coal worker’s pneumoconiosis, the role of 
smoking in causing fibrosis is insignificant in comparison with that of silica/silicate 
particles from coal mine dust [18]. Since smoking and coal mine dust simultane-
ously may cause pulmonary fibrosis and emphysema by destruction of lung tissue 
and healing by fibrosis, it is plausible that in some patients emphysema is dominant, 
in others interstitial fibrosis, and in some others combined pulmonary fibrosis and 
emphysema syndrome (Figure 11) may occur [18, 19].
Alpha-1 antitrypsin deficiency is not the only one known genetic cause of emphy-
sema. Telomere length is also associated with emphysema [20]. Both tips (ends) of the 
chromosomes are capped (protected) by telomeres composed of tandemly repeated 
DNA sequences. Telomeres are highly conserved and practically identical from proto-
zoa to vertebrates. In humans, the TTAGGG repeat region is 10–15 kilobytes long. With 
each mitosis terminal nucleotides at the tail of telomeres are lost, and telomeres become 
shorter with each cell division. When telomere becomes critically short, the cell cannot 
Figure 10. 
Initial event in development of emphysema and interstitial fibrosis in coal miners is appearance of 
macrophages laden with silica and silicate particles and anthracotic pigment inside alveoli. Hematoxylin 
and eosin stain, original magnification 400×. Right side, same picture under polarized light to demonstrate 
birefringent silica and silicate particles in the cytoplasm of macrophages. Very small and faint white dots are 
silica particles, and small bright dots are silicate particles.
Figure 11. 
Tobacco caused emphysema and tobacco caused respiratory bronchiolitis-associated interstitial lung disease with 
fibrosis, called combined pulmonary fibrosis and emphysema syndrome. Courtesy of Dr. Nadia N. Naumova.
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divide anymore and thus becomes an old cell that will finally end up in apoptosis. 
Telomerase is an enzyme that synthesizes telomeres. Mutations in telomerase gene and 
telomere genes cause short telomere length for cell age and disease spectrum called 
short telomere syndrome/accelerated aging syndrome. The main presentation (90%) of 
short telomere syndromes are idiopathic pulmonary (interstitial) fibrosis and emphy-
sema. They may be associated with other features of premature aging including early 
graying, osteoporosis, liver disease, predisposition to bone marrow failure, infertility, as 
well as myelodysplastic syndrome and acute myeloid leukemia [21]. Reduced telomere 
length may be identified in 25% of patients with sporadic idiopathic pulmonary 
fibrosis and half of those cases with family aggregation [22]. Telomerase deficiency and 
telomere shortening are responsible for only 1% of all emphysemas but are conceptually 
important as a link between interstitial fibrosis, emphysema, combined emphysema 
and interstitial fibrosis, and effect of environment on phenotypic presentation of 
genetic defect [21]. Pathogenic mechanism is premature senescence of alveolar epithe-
lial stem cells, their apoptosis, disappearance of alveoli (emphysema), and abnormal 
repair with excessive interstitial fibrosis. The same genetic change, germline deletion in 
the Box H domain of the RNA telomerase, can cause in the father idiopathic pulmonary 
fibrosis, in one daughter emphysema, and in the other daughter combined pulmonary 
fibrosis and emphysema syndrome [20]. Interaction between the gene and environ-
ment determines lung disease. Never-smokers develop pulmonary interstitial fibrosis, 
while smokers develop an early onset emphysema alone or combined emphysema and 
pulmonary interstitial fibrosis [20, 21]. Cigarette smoke causes additive DNA damage to 
telomere function, and genetic defect in this setting expresses as emphysema [20].
In short, the main causes of emphysema and interstitial fibrosis are cigarette 
smoking and in coal miners silica and silicate particles from coal dust. Hereditary 
emphysemas caused by alpha-1 antitrypsin deficiency and short telomere length are 
epidemiologically insignificant but can help to elucidate pathogenesis of emphysema 
and interstitial fibrosis. Not all smokers develop emphysema and chronic obstructive 
pulmonary disease. Only 10–20% of the smokers develop chronic obstructive pulmo-
nary disease pointing at an additional risk factor such as genetic susceptibility reflected 
in polymorphisms in genes coding for various antiproteases, a disintegrin, and metal-
loproteinase 33 or antioxidant superoxide dismutase and proinflammatory media-
tors including tumor necrosis factor-alpha [10] and possibly genes associated with 
telomeres. Combined pulmonary fibrosis and emphysema are also in the vast majority 
of cases caused by cigarette smoking or in coal miners by coal dust, and the above 
mentioned genetic factors might contribute to a now unknown degree of susceptibility.
Patients with emphysema only are extremely rare, and in practice emphysema 
is component of the chronic obstructive pulmonary disease which affects about 24 
million people in the USA. Chronic bronchitis is chronic mucous hypersecretion 
syndrome and is clinically defined as productive cough for at least 3 months in 2 suc-
cessive years. Its pathohistological features (Figure 12) include enlargement of the 
mucus-secreting glands in the bronchial wall, goblet cell metaplasia of the respira-
tory epithelium, infiltration of the bronchial mucosa with lymphocytes, squamous 
metaplasia and dysplasia in the bronchial epithelium, increased bronchial smooth 
muscle, as well as mucous plugging, inflammation, and fibrosis of the bronchioles.
Chronic bronchitis becomes chronic obstructive bronchitis when airflow obstruc-
tion occurs. It can be detected by spirometry or expiratory wheezing can be heard by 
auscultation. Bronchial airways are being compressed during expiration, and expira-
tion is in chronic obstructive bronchitis difficult and prolonged. Auscultation reveals 
diminished breath sounds, prolonged expiratory phase, and expiratory wheezing. 
The main airflow obstruction occurs in small airways, with diameter less than 2 mm. 
Obstruction is caused by mucosal thickening, due to lymphocytic infiltration, fibrosis, 
edema, mucous plugging, and smooth muscle hypertrophy. Figure 13 demonstrates 
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thickening of the wall of the terminal bronchiolus by fibrous tissue and smooth muscle 
hypertrophy caused by birefringent silica/silicate particles from coal mine dust.
Clara cells that secrete surfactant are replaced by goblet cells, and decrease of 
surfactant increases surface tension at the air-tissue interface, and small bronchi and 
bronchiole are prone to collapse. Emphysema also contributes to airflow obstruc-
tion. Destruction and disappearance of respiratory bronchiole and alveolar ducts 
decrease total airway diameter. Destruction of acinar tissue with disappearance of 
elastic fibers decreases lung recoil and decreases expiratory air force. The net effect 
of chronic obstructive pulmonary disease is difficulty in breathing, prolonged 
expiration with expiratory wheezing, air trapping in the lungs with hyperinflation 
of lungs, increased residual volume, decreased vital capacity, and dyspnea.
Three cardinal features of chronic obstructive pulmonary disease are cough, 
sputum production, and exertional dyspnea. Dyspnea during physical activity may 
start insidiously, and patients complain of difficult breathing, gasping and air hunger, 
heaviness in chest in the beginning only during rather heavy physical work and later 
during light daily physical activity. Patients with chronic obstructive pulmonary 
disease poorly tolerate physical activity with arms but tolerate better physical work 
like pushing shopping cart when arms are fixed and enable the use of accessory 
respiratory muscles [1]. Acute exacerbations of chronic obstructive pulmonary 
Figure 12. 
Chronic bronchitis presenting with mucus in the lumen of the bronchus, partial goblet cell metaplasia of the 
respiratory epithelium, predominance of the mucinous cells in the bronchial exocrine gland, infiltration the 
bronchial wall by small lymphocytes and plasma cells, hypertrophy of the muscle layer, and peribronchial fibrosis.
Figure 13. 
The wall of the terminal bronchiolus is thickened by fibrosis and smooth muscle hypertrophy and this is one 
of the essential pathologic bases for obstructive pulmonary disease. Birefringent silica and silicate particles are 
etiological factor. Hematoxylin and eosin stain, original magnification 200×, polarized light.
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disease are prominent feature of its natural history and are characterized by cough, 
increase in amount and character (color) of sputum, and dyspnea and may or may 
not be accompanied with fever, myalgia, and sore throat. The health-related qual-
ity of life of patients with chronic obstructive pulmonary disease better correlates 
(inverse correlation) with frequency of acute exacerbations than with the degree 
of airflow obstruction (Reilly-Harrison). Patients with advanced emphysema due 
to hyperinflation of lungs have barrel chest with poor diaphragmatic excursion as 
assessed by percussion and dramatic decrease in breath sounds and are sitting in the 
characteristic tripod position with stretched fixed arms to enable the use of accessory 
respiratory muscles including sternocleidomastoid, scalene, and intercostal ones [1]. 
Patients with predominant emphysema are called “pink puffers” because they breathe 
through pursed lips with the help of accessory respiratory muscles. When small 
airway obstruction ensues, patients become hypoxic and cyanotic in the lips and nail 
beds, and when fluid retains due to right heart decompensation, they become “blue 
bloaters.” However the majority of chronic obstructive pulmonary disease patients 
have some signs of both, “pink puffers” and “blue bloaters.” Advanced chronic 
obstructive lung disease is accompanied by systemic wasting due to high energy 
expenditure for increased work of breathing muscles including accessory breathing 
muscles and elevated levels of inflammatory cytokines including tumor necrosis 
factor-alpha. Such patients have a significant weight loss and diffuse loss of subcu-
taneous fatty tissue. Some patients with advanced chronic obstructive pulmonary 
disease have paradoxical inward movement of the lower rib cage (Hoover sign) due 
to diaphragmatic contraction in a setting of permanently hyperinflated lungs [1]. 
Advanced chronic obstructive pulmonary disease, especially during acute exacerba-
tion, can be accompanied by right heart failure. Signs include right ventricular heave, 
third heart sound, distended jugular veins, congested liver, ascites, and edema of legs.
2.3 Radiologic findings
Cardinal features of emphysema, hyperinflation of the lungs, and lung tissue 
destruction can be visualized by radiologic means. On the chest roentgenogram 
hyperinflation presents with increased lucency, increased retrosternal air space, 
depression and flattening of the diaphragm. Lung destruction presents in focal 
lucencies and areas of decreased vascularity. Mild emphysema is usually missed by 
standard chest X-rays.
High-resolution computerized tomography is superior to the chest X-ray in detect-
ing emphysema. High-resolution computerized tomography can visualize focal areas 
of decreased attenuation sharply circumscribed without visible walls and with small 
centrilobular vessel in the areas of emphysema [3]. Several studies showed good cor-
relation between the degree of pathologic findings and high-resolution computerized 
tomography findings [23]. However, mild focal areas might not be detected, and high-
resolution computerized tomography cannot be used to rule out emphysema [24].
2.4 Tests of pulmonary function
Spirometry and pulse oximetry are basic simple pulmonary function tests that 
can be performed in the ambulatory settings. The patient exhales in the spirometry 
instrument as completely as possible, then forcibly inhales as much as possible, and 
then forcibly exhales as much as possible. Forced vital capacity is the maximum 
amount of air forcibly expired after maximum inspiration. Residual volume is 
amount of air retained in the lungs after maximal and forceful exhalation, and it 
can be calculated after using gas dilution technique or body-box plethysmography. 
In the emphysema due to the destruction of respiratory bronchioles, spirometry 
13
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
Emphysema
DOI: http://dx.doi.org/10.5772/intechopen.83273
will demonstrate obstructive pattern. Forced expiratory volume in 1 second will be 
decreased. Alveolar destruction in emphysema decreases amount of lung paren-
chyma, and thus forced vital capacity will decrease. Essentially emphysema is a 
mixed lung disorder, both obstructive and restrictive.
Transcutaneous pulse oximetry estimates oxygen (O2) saturation of capil-
lary blood using instrument in shape of clip positioned on a finger. Estimation is 
accurate and correlates to 5% of measured atrial O2 saturation obtained by invasive 
procedure.
2.5 Therapy
Centriacinar emphysema is a progressive disabling disease for which there are no 
good therapeutic options. Large bullae that compress functional lung tissue can be 
surgically removed. Patients with severe, predominantly upper lung emphysema, 
and low baseline exercise capacity may benefit from lung volume reduction by 
resection, including bronchoscopic lung volume reduction, of non-functioning 
emphysematous areas. Dyspnea decreases because of reduced hyperinflation 
and residual volume and because forced expiration volume in the first second is 
increased [25]. Exercise tolerance and 2-year mortality rate are improved sup-
posedly to decreased residual lung volume, enhanced lung recoil, and improved 
diaphragmatic function. Long-term effects of the lung volume reduction surgery 
are unknown. Improvement after lung transplantation is better than after the lung 
volume reduction surgery. Candidates for lung transplantation are younger than 
60 years, with an FEV1 less than 25% predicted or pulmonary artery hyperten-
sion. The 5-year survival after transplantation for emphysema is 45–60%. Lifelong 
immunosuppression brings risk of opportunistic infections.
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